FAM
Fred Alger Management Portfolio holdings
AUM
$22.3B
1-Year Return
57.87%
This Quarter Return
+12.48%
1 Year Return
+57.87%
3 Year Return
+264.72%
5 Year Return
+406.03%
10 Year Return
+1,631.73%
AUM
$20.1B
AUM Growth
+$1.71B
(+9.3%)
Cap. Flow
-$141M
Cap. Flow
% of AUM
-0.7%
Top 10 Holdings %
Top 10 Hldgs %
38.54%
Holding
575
New
91
Increased
134
Reduced
234
Closed
49
Top Buys
| 1 |
Walt Disney
DIS
|
$221M |
| 2 |
Apple
AAPL
|
$146M |
| 3 |
Microchip Technology
MCHP
|
$137M |
| 4 |
T-Mobile US
TMUS
|
$126M |
| 5 |
Cognizant
CTSH
|
$122M |
Top Sells
| 1 |
Alphabet (Google) Class C
GOOG
|
$391M |
| 2 |
NXP Semiconductors
NXPI
|
$168M |
| 3 |
Newell Brands
NWL
|
$163M |
| 4 |
Electronic Arts
EA
|
$147M |
| 5 |
Biogen
BIIB
|
$143M |
Sector Composition
| 1 | Technology | 25.01% |
| 2 | Communication Services | 18.63% |
| 3 | Healthcare | 14.3% |
| 4 | Consumer Discretionary | 12.48% |
| 5 | Financials | 9.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
326
Cheniere Energy
CQP
$26.1B
| $978K | ﹤0.01% |
30,266
| – | – |
|
|
STI
327
DELISTED
SunTrust Banks, Inc.
STI
| $950K | ﹤0.01% |
17,172
-109
| -0.6% | -$6.03K |
|
328
United Therapeutics
UTHR
$18.1B
| $948K | ﹤0.01% |
+7,000
| New | +$948K |
|
329
Lockheed Martin
LMT
$108B
| $910K | ﹤0.01% |
3,402
-356,202
| -99% | -$95.3M |
|
|
BIVV
330
DELISTED
Bioverativ Inc. Common Stock
BIVV
| $900K | ﹤0.01% |
+16,535
| New | +$900K |
|
331
LKQ Corp
LKQ
$8.33B
| $860K | ﹤0.01% |
29,381
-58,250
| -66% | -$1.71M |
|
332
SAP
SAP
$313B
| $854K | ﹤0.01% |
8,701
-1,484
| -15% | -$146K |
|
333
Mattel
MAT
$6.06B
| $820K | ﹤0.01% |
32,038
-247,827
| -89% | -$6.34M |
|
334
Mettler-Toledo International
MTD
$26.9B
| $814K | ﹤0.01% |
+1,700
| New | +$814K |
|
335
3M
MMM
$82.7B
| $810K | ﹤0.01% |
5,065
+1,048
| +26% | +$168K |
|
336
EOG Resources
EOG
$64.4B
| $807K | ﹤0.01% |
8,269
-139,866
| -94% | -$13.7M |
|
337
VF Corp
VFC
$5.86B
| $805K | ﹤0.01% |
15,556
+45
| +0.3% | +$2.33K |
|
338
Align Technology
ALGN
$10.1B
| $803K | ﹤0.01% |
+7,000
| New | +$803K |
|
339
American International
AIG
$43.9B
| $797K | ﹤0.01% |
12,768
-89
| -0.7% | -$5.56K |
|
340
Neurocrine Biosciences
NBIX
$14.3B
| $753K | ﹤0.01% |
17,394
-32,489
| -65% | -$1.41M |
|
341
Lincoln National
LNC
$7.98B
| $729K | ﹤0.01% |
11,136
-2,963
| -21% | -$194K |
|
342
Berkshire Hathaway Class B
BRK.B
$1.08T
| $693K | ﹤0.01% |
4,157
| – | – |
|
343
Allegion
ALLE
$14.8B
| $681K | ﹤0.01% |
8,992
-40,246
| -82% | -$3.05M |
|
344
Merck
MRK
$212B
| $669K | ﹤0.01% |
11,030
-1,881
| -15% | -$114K |
|
345
Exelixis
EXEL
$10.2B
| $650K | ﹤0.01% |
30,000
+17,000
| +131% | +$368K |
|
346
Galapagos
GLPG
$2.2B
| $646K | ﹤0.01% |
+7,500
| New | +$646K |
|
347
Tetra Tech
TTEK
$9.48B
| $644K | ﹤0.01% |
78,825
-48,170
| -38% | -$394K |
|
|
NBIS
348
Nebius Group N.V. Class A Ordinary Shares
NBIS
$15.6B
| $642K | ﹤0.01% |
29,288
-400
| -1% | -$8.77K |
|
|
BLCM
349
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
| $617K | ﹤0.01% |
5,000
+300
| +6% | +$37K |
|
|
TVTY
350
DELISTED
Tivity Health, Inc. Common Stock
TVTY
| $611K | ﹤0.01% |
+21,000
| New | +$611K |
|